ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on microRNA expression profiling

Xu Ya Fei; Li Ying Qin; Guo Rui; He Qing Mei; Ren Xian Yue; Tang Xin Ran; Jia Wei Hua; Kang Tie Bang; Zeng Mu Sheng; Sun Ying; Ma Jun*; Liu Na
The International Journal of Biochemistry and Cell Biology2015-4DOI: 10.1016/j.biocel.2015.02.006
4被引6阅读
引用收藏
分享

摘要

Recent evidence has indicated that miRNAs play important roles in carcinogenesis. The identification of dysregulated miRNAs and the target genes they regulate might enhance our understanding of the molecular mechanisms of nasophalyngeal carcinoma (NPC). A microarray analysis was performed to identify dysregulated miRNAs in NPC tissue samples, and protein-coding genes targeted by three or more downregulated miRNAs were selected using miRWalk and used in a pathway enrichment analysis. Nineteen KEGG pathways were selected by DAVID, including the MAPK, focal adhesion, gap junction, ECM-receptor interaction, TGF-beta, and p53 signalling pathways, most of which are involved in NPC carcinogenesis and progression. MiR-143 was significantly downregulated in NPC cell lines and clinical samples. The ectopic expression of miR-143 suppressed NPC cell viability, colony formation, and anchorage-independent growth in vitro, and it inhibited xenograft tumour growth in vivo. Furthermore, KRAS was confirmed as a direct target of miR-143, and silencing KRAS expression suppressed NPC cell viability and proliferation. The miR-143/KRAS pathway provides new insight into the molecular mechanisms that regulate the development and progression of NPC, and it provides novel therapeutic targets for NPC.

学科与关键词

关键词
Nasopharyngeal carcinomaSignalling pathwaymiR-143KRASTumour growth
相关
加载中…
  • Upregulated microRNA-143 inhibits cell proliferation in human nasopharyngeal carcinoma
    He Benfu; Xu Zhe; Chen Jinzhang; Zheng Dayong; Li Aimin; Zhang Luo ShengOncology Letters, 2016, 12(6): 5023-5028.
  • Down-regulation of microRNA-143 contributes to unfavorable prognosis for patients with nasopharyngeal carcinoma
    Zhang Haipeng; Huang Ying; Qiao Feng; Ding Xuerui; Ma XiaoyanInternational Journal of Clinical and Experimental Pathology, 2016, 9(2): 2044-2048.
  • MicroRNA-124-3p inhibited progression of nasopharyngeal carcinoma by interaction with PCDH8 and the inactivation of PI3K/AKT/mTOR pathway
    Ye, Jiacai; Liao, Quanxing; Zeng, Xiaohui; Liu, Chang; Ding, Yan; Liu, Xuefeng; Zeng, Lisi*; Guan, Tianpei*; Yuan, Yawei*American Journal of Cancer Research, 2021, 12(16): 4933-4944.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
The International Journal of Biochemistry and Cell Biology
发表日期
2015-04
卷期
第 61 卷
页码
120-128
DOI
10.1016/j.biocel.2015.02.006
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q2
成果收录
SCI
资助标注
National Natural Science Foundation of China [81230056, 81402516]; Pearl River Science and Technology New Star of Guangzhou, China; Science and Technology Project of Guangzhou City [12BppZXaa2060002]; Health & Medical Collaborative Innovation Project of Guangzhou City [201400000001]; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2014BAI09B10]; Innovation Team Development Plan of the Ministry of Education [IRT1297]; Key Laboratory Construction Project of Guangzhou City [121800085]; Guangdong Department of Science & Technology Translational Medicine Center grant [2011A080300002]

作者

  • X

    Xu Ya Fei (第一作者)

  • L

    Li Ying Qin

查看全部 12 位作者收起作者
  • G

    Guo Rui

  • H

    He Qing Mei

  • R

    Ren Xian Yue

  • T

    Tang Xin Ran

  • J

    Jia Wei Hua

  • K

    Kang Tie Bang

  • Z

    Zeng Mu Sheng

  • S

    Sun Ying

  • M

    Ma Jun (通讯)

  • L

    Liu Na

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417